• DOI:10.1007/s10067-006-0315-1
Corpus ID: 26017061

Prevention and treatment strategies for glucocorticoid-induced osteoporotic fractures

@article{Gourlay2006PreventionAT,
  title={Prevention and treatment strategies for glucocorticoid-induced osteoporotic fractures},
  author={M. Gourlay and N. Franceschini and Yevgeniy Sheyn},
  journal={Clinical Rheumatology},
  year={2006},
  volume={26},
  pages={144-153}
}

M. Gourlay, N. Franceschini, Yevgeniy Sheyn

Published 2006

Medicine

Clinical Rheumatology

Glucocorticoids are the most common cause of drug-related osteoporosis. We reviewed current evidence on risk factors for glucocorticoid-induced osteoporosis (GIOP) and prevention and treatment of GIOP-related fractures. Guidelines for GIOP management published since 2000 were also reviewed. Significant bone loss and increased fracture risk is seen with daily prednisone doses as low as 5 mg. Alternate-day glucocorticoid therapy can lead to similar bone loss. No conclusive evidence exists for a… CONTINUE READING

View on Springer

ncbi.nlm.nih.gov

Save to Library

Create Alert

Cite

Launch Research Feed